UnitedHealth Group market cap is $404 b, and annual revenue was $257.14 b in FY 2020

UnitedHealth Group Gross profit (Q1, 2021)62.6 B

UnitedHealth Group Gross profit margin (Q1, 2021), %89.2%

UnitedHealth Group Net income (Q1, 2021)5 B

UnitedHealth Group EBIT (Q1, 2021)6.7 B

UnitedHealth Group Cash, 31-Mar-202120 B

UnitedHealth Group EV430.3 B

UnitedHealth Group revenue was $257.14 b in FY, 2020

UnitedHealth Group revenue breakdown by business segment: 62.8% from UnitedHealthcare, 9.8% from OptumHealth, 24.1% from OptumRx and 3.2% from Other

UnitedHealth Group revenue breakdown by geographic segment: 48.0% from United States, 48.0% from United States and 4.0% from Other

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Revenue | 201.2b | 226.2b | 242.2b | 257.1b |

| 9% | 12% | 7% | |

## Cost of goods sold | 154.1b | 172.4m | 184.6b | 30.7b |

## Gross profit | 47.0b | 53.8b | 57.6b | 226.4b |

| 23% | 24% | 24% | 88% |

## General and administrative expense | 29.6b | 34.1b | 35.2b | 41.7b |

## Operating expense total | 31.8b | 36.5b | 37.9b | 204.0b |

## Depreciation and amortization | 2.2b | 2.4b | 2.7b | 2.9b |

## EBIT | 15.2b | 17.3b | 19.7b | 22.4b |

| 8% | 8% | 8% | 9% |

## Interest expense | 1.2b | 1.4b | 1.7b | |

## Interest income | 1.5b | |||

## Pre tax profit | 14.0b | 15.9b | 18.0b | 20.7b |

## Income tax expense | 3.2b | 3.6b | 3.7b | 5.0b |

## Net Income | 10.8b | 12.4b | 14.2b | 15.8b |

## EPS | 10.7 | 12.2 | 14.3 |

- Source: SEC Filings

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
---|---|---|---|---|---|---|---|---|---|---|

## Revenue | 55.2b | 56.1b | 56.6b | 60.3b | 60.6b | 60.4b | 64.4b | 62.1b | 65.1b | 70.2b |

## Cost of goods sold | 42.0b | 42.9b | 42.9b | 46.3b | 46.8b | 45.7b | 48.7b | 42.2b | 49.6b | 7.6b |

## Gross profit | 13.1b | 13.2b | 13.7b | 14.0b | 13.8b | 14.7b | 15.7b | 20.0b | 15.5b | 62.6b |

| 24% | 24% | 24% | 23% | 23% | 24% | 24% | 32% | 24% | 89% |

## General and administrative expense | 8.5b | 8.4b | 8.5b | 8.5b | 8.4b | 9.0b | 10.0b | 10.0b | 10.2b | 10.2b |

## Operating expense total | 9.1b | 9.0b | 9.1b | 9.2b | 9.1b | 9.7b | 10.7b | 10.7b | 10.9b | 55.9b |

## Depreciation and amortization | 582.0m | 598.0m | 611.0m | 639.0m | 654.0m | 709.0m | 723.0m | 717.0m | 719.0m | |

## EBIT | 4.1b | 4.2b | 4.6b | 4.8b | 4.7b | 5.0b | 5.0b | 9.2b | 4.7b | 6.7b |

| 7% | 7% | 8% | 8% | 8% | 8% | 8% | 15% | 7% | 10% |

## Interest expense | 329.0m | 344.0m | 353.0m | 400.0m | 418.0m | 449.0m | 437.0m | 430.0m | 395.0m | 397.0m |

## Interest income | 452.0m | |||||||||

## Pre tax profit | 3.7b | 3.9b | 4.2b | 4.4b | 4.3b | 4.6b | 4.6b | 8.8b | 4.3b | 6.3b |

## Income tax expense | 800.0m | 850.0m | 953.0m | 875.0m | 941.0m | 936.0m | 1.1b | 2.1b | 1.0b | 1.4b |

## Net Income | 2.9b | 3.0b | 3.3b | 3.5b | 3.3b | 3.5b | 3.5b | 6.7b | 3.3b | 5.0b |

## EPS | 2.9 | 3.0 | 3.2 | 3.6 | 3.4 | 3.7 | 3.5 | 6.9 | 3.3 |

- Source: SEC Filings

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Cash | 12.0b | 10.9b | 11.0b | 16.9b |

## Accounts Receivable | 9.6b | 11.4b | 11.8b | 12.9b |

## Prepaid Expenses | 2.7b | 3.1b | 3.9b | 4.5b |

## Current Assets | 37.1b | 38.7b | 42.6b | 53.7b |

## PP&E | 7.0b | 8.5b | 8.7b | 8.6b |

## Goodwill | 54.6b | 58.9b | 65.7b | 71.3b |

## Total Assets | 139.1b | 152.2b | 173.9b | 197.3b |

## Accounts Payable | 15.2b | 16.7b | 19.0b | 22.5b |

## Short-term debt | 2.9b | 2.0b | 3.9b | 4.8b |

## Current Liabilities | 50.5b | 53.2b | 61.8b | 72.4b |

## Long-term debt | 28.8b | 34.6b | 36.8b | 38.6b |

## Total Debt | 31.7b | 36.6b | 40.7b | 43.5b |

## Total Liabilities | 87.0b | 96.0b | 111.7b | 126.8b |

## Common Stock | 10.0m | 10.0m | 9.0m | 10.0m |

## Preferred Stock | ||||

## Additional Paid-in Capital | 1.7b | 7.0m | ||

## Retained Earnings | 48.7b | 55.8b | 61.2b | 69.3b |

## Total Equity | 49.8b | 54.3b | 60.4b | 68.3b |

## Debt to Equity Ratio | 0.6 x | 0.7 x | 0.7 x | |

## Debt to Assets Ratio | 0.2 x | 0.2 x | 0.2 x | |

## Financial Leverage | 2.8 x | 2.8 x | 2.9 x | 2.9 x |

- Source: SEC Filings

- Source: SEC Filings

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Net Income | 10.8b | 12.4b | 14.2b | 15.8b |

## Depreciation and Amortization | 2.2b | 2.4b | 2.7b | 2.9b |

## Accounts Receivable | (1.1b) | (1.4b) | 162.0m | (688.0m) |

## Accounts Payable | 930.0m | 526.0m | 733.0m | 5.3b |

## Cash From Operating Activities | 13.6b | 15.7b | 18.5b | 22.2b |

## Purchases of PP&E | (2.0b) | (2.1b) | (2.1b) | (2.1b) |

## Cash From Investing Activities | (8.6b) | (12.4b) | (12.7b) | (12.5b) |

## Long-term Borrowings | (4.4b) | (2.8b) | (1.7b) | (3.1b) |

## Dividends Paid | (2.8b) | (3.3b) | (3.9b) | (4.6b) |

## Cash From Financing Activities | (3.4b) | (4.4b) | (5.6b) | (3.6b) |

## Net Change in Cash | 1.6b | (1.1b) | 119.0m | 5.9b |

## Interest Paid | 1.1b | 1.4b | 1.6b | 1.7b |

## Income Taxes Paid | 4.0b | 3.3b | 3.5b | 4.9b |

- Source: SEC Filings

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
---|---|---|---|---|---|---|---|---|---|---|

## Net Income | 2.9b | 5.9b | 9.2b | 3.6b | 6.9b | 10.6b | 3.5b | 10.2b | 13.4b | 4.9b |

## Depreciation and Amortization | 582.0m | 1.2b | 1.8b | 639.0m | 1.3b | 2.0b | 723.0m | 1.4b | 2.2b | 758.0m |

## Accounts Receivable | (1.6b) | (1.0b) | (984.0m) | (1.4b) | 2.2b | 957.0m | (2.7b) | (439.0m) | (194.0m) | (2.9b) |

## Accounts Payable | 2.8b | 2.2b | 2.8b | 318.0m | (33.0m) | 105.0m | 4.1b | 7.6b | 3.4b | 870.0m |

## Cash From Operating Activities | 8.4b | 12.4b | 13.3b | 3.2b | 9.1b | 12.3b | 2.9b | 12.9b | 16.1b | 6.0b |

## Purchases of PP&E | (477.0m) | (960.0m) | (1.5b) | (562.0m) | (977.0m) | (1.4b) | (469.0m) | (920.0m) | (1.5b) | (568.0m) |

## Cash From Investing Activities | (4.5b) | (6.7b) | (11.2b) | (1.4b) | (6.9b) | (11.3b) | (1.5b) | (4.5b) | (7.4b) | (3.7b) |

## Long-term Borrowings | (1.1b) | (1.3b) | (2.8b) | (1.2b) | (1.2b) | (1.2b) | (1.5b) | (1.1b) | ||

## Dividends Paid | (722.0m) | (1.6b) | (2.5b) | (860.0m) | (1.9b) | (2.9b) | (1.0b) | (2.2b) | (3.4b) | (1.2b) |

## Cash From Financing Activities | 2.4b | 787.0m | (3.7b) | (272.0m) | 643.0m | 587.0m | 9.3b | 3.0b | (2.0b) | 787.0m |

## Net Change in Cash | 6.3b | 6.4b | (1.7b) | 1.5b | 2.9b | 1.5b | 10.6b | 11.3b | 6.6b | 3.0b |

- Source: SEC Filings

USD | FY, 2017 |
---|---|

## Revenue/Employee | 773.7k |

## Debt/Equity | 0.6 x |

## Debt/Assets | 0.2 x |

## Financial Leverage | 2.8 x |

FY, 2017 | FY, 2018 | FY, 2019 | |
---|---|---|---|

## Physicians | 1.2 m | 1.3 m | 1.4 m |

## Hospitals | 6.5 k | 6 k | 6.5 k |

## Customers Served (UnitedHealthcare Employer & Individual) | 27 m | 27 m | 27.8 m |

## Customers Served (UnitedHealthcare Medicare & Retirement) | 4.4 m | 4.9 m | 5.3 m |

## Customers Served (UnitedHealthcare Community & State) | 6.7 m | 6.5 m | 5.9 m |

## Customers Served (UnitedHealthcare Global) | 4 m | 6.2 m | 8 m |

## Customers Served (OptumHealth) | 91 m | 93 m | 96 m |

## Customers Served (OptumRx) | 65 m | 65 m | 56 m |

## Backlog (OptumInsight) | $15 b | $17 b | $19.3 b |

## Physicians (OptumInsight) | 100 k | 100 k | 100 k |

## Retail Pharmacies (OptumRx) | 67 k | 67 k | 67 k |

- Source: SEC Filings

Y, 2019 | Y, 2018 | Y, 2017 | |
---|---|---|---|

Female (USA), percent | 25.2% | 25.2% | 25.5% |

Male (Management), percent | 12.1% | 12.1% | 11.7% |

Female (Management), percent | 19% | 19% | 19.3% |

Male, percent | 10.7% | 11.7% | 10.7% |

Female, percent | 23.8% | 22.8% | 23.8% |

Male (USA), percent | 9.3% | 9.3% | 9% |

- Source: www.unitedhealthgroup.com

Y, 2019 | Y, 2018 | Y, 2017 | |
---|---|---|---|

Other Ethnicity (USA), percent | 60% | 62% | 62% |

People of Color (USA), percent | 40% | 38% | 38% |

- Source: www.unitedhealthgroup.com